CIBC World Market’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Hold
3,048
﹤0.01% 1380
2026
Q1
$271K Hold
3,048
﹤0.01% 1301
2025
Q4
$290K Hold
3,048
﹤0.01% 1263
2025
Q3
$301K Hold
3,048
﹤0.01% 1234
2025
Q2
$325K Sell
3,048
-1
-0% -$101 ﹤0.01% 1160
2025
Q1
$278K Sell
3,049
-110
-3% -$12.3K ﹤0.01% 1182
2024
Q4
$360K Buy
+3,159
New +$360K ﹤0.01% 1126
2023
Q2
Sell
-1,806
Closed -$225K 1218
2023
Q1
$225K Hold
1,806
﹤0.01% 1120
2022
Q4
$271K Buy
1,806
+246
+16% +$37.9K ﹤0.01% 1094
2022
Q3
$210K Sell
1,560
-1,386
-47% -$212K ﹤0.01% 1126
2022
Q2
$439K Sell
2,946
-37
-1% -$5.65K ﹤0.01% 910
2022
Q1
$509K Buy
2,983
+180
+6% +$30.2K ﹤0.01% 928
2021
Q4
$723K Buy
2,803
+1,955
+231% +$535K ﹤0.01% 869
2021
Q3
$231K Buy
+848
New +$270K ﹤0.01% 1209
2021
Q1
Sell
-2,497
Closed -$204K 1293
2020
Q4
$204K Buy
+2,497
New +$245K ﹤0.01% 1198

Other funds holding BNTX

CIBC World Market's BNTX Position: Q2 2026 in Review

CIBC World Market held its BioNTech (BNTX) position steady in Q2 2026 at 3,048 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

CIBC World Market first reported a position in BNTX in Q4 2020 and has held it in 15 quarters since. The position peaked at $723K in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • CIBC World Market held 3,048 shares of BioNTech worth $284K as of Q2 2026.
  • CIBC World Market left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1380 holding.
  • CIBC World Market first reported a position in BioNTech in Q4 2020 and has held it in 15 quarters since.
  • CIBC World Market's BioNTech position peaked at $723K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.